Tempest Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Tempest Therapeutics, Inc. (TPST) had Lessee, Operating Lease, Liability, to be Paid, Year One of $2.61 million as of 2022-12-31, per its 10-K filed 2023-03-22.
Discontinued › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2023-03-22
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $2.61M.
- 2022-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.65M.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.60M.
- 2021-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $1.60M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2022-12-31 | $2.61M 10-K · filed 2023-03-22 |
| 2022-03-31 | $1.65M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $1.60M 10-K · filed 2022-03-29 |
| 2021-09-30 | $1.60M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.60M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $783.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $760.00K 10-K · filed 2021-03-29 |
| 2020-09-30 | $760.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $760.00K 10-Q · filed 2020-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |